Lycopene used as Anti-inflammatory Nanodrug for the Treatment of Rheumathoid Arthritis: Animal assay, Pharmacokinetics, ABC Transporter and Tissue Deposition
- 1 April 2020
- journal article
- research article
- Published by Elsevier BV in Colloids and Surfaces B: Biointerfaces
- Vol. 188, 110814
- https://doi.org/10.1016/j.colsurfb.2020.110814
Abstract
No abstract availableKeywords
Funding Information
- FAPERJ
- CNPq
- CAPES
This publication has 43 references indexed in Scilit:
- Multiple Molecular and Cellular Mechanisms of Action of Lycopene in Cancer InhibitionEvidence-Based Complementary and Alternative Medicine, 2013
- Studies on the cell biology of interendothelial cell gapsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2012
- Effects of Nanoparticle Size on Cellular Uptake and Liver MRI with Polyvinylpyrrolidone-Coated Iron Oxide NanoparticlesACS Nano, 2010
- An Update on the Health Effects of Tomato LycopeneAnnual Review of Food Science and Technology, 2010
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- Pharmacokinetics and Biodistribution of NanoparticlesMolecular Pharmaceutics, 2008
- Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-α, and CXCL-1Journal of Leukocyte Biology, 2008
- Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drugAnnals Of The Rheumatic Diseases, 2006
- Drug efflux transporters in rheumatoid arthritis: Comment on the article by KremerArthritis & Rheumatism, 2005
- Lycopene in Tomatoes: Chemical and Physical Properties Affected by Food ProcessingCritical Reviews in Biotechnology, 2000